Peter Kang

Peter Kang is a pediatric neuromuscular neurologist and physician-scientist who leads a research laboratory that studies genomic dilemmas, disease mechanisms, and potential new therapies in muscular dystrophy, and has published extensively in these areas. His laboratory recently led the discovery of a new muscular dystrophy gene, JAG2, and is pioneering the application of nanopore long read genome sequencing to muscular dystrophy diagnostic dilemmas. He is the Director of the Paul & Sheila Wellstone Muscular Dystrophy Center, and Professor and Vice Chair of Research for the Department of Neurology at the University of Minnesota. He is an associate editor at Muscle & Nerve, and is on the editorial board of Neurology. He has been the PI on grants from the NIH, CDC, Muscular Dystrophy Association (MDA), National Initiative for Cockayne Syndrome, and Xtraordinary Joy Foundation. He was previously Chair of the Section on Neurology of the American Academy of Pediatrics and Secretary-Treasurer of the Massachusetts Medical Society. He will take office as President-Elect of the Child Neurology Society in October 2022.